Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Column leaching of low-grade saprolitic laterites and valorization of leaching residues.

Komnitsas K, Petrakis E, Bartzas G, Karmali V.

Sci Total Environ. 2019 May 15;665:347-357. doi: 10.1016/j.scitotenv.2019.01.381. Epub 2019 Jan 30.

PMID:
30772565
2.

CD163+ macrophages promote angiogenesis and vascular permeability accompanied by inflammation in atherosclerosis.

Guo L, Akahori H, Harari E, Smith SL, Polavarapu R, Karmali V, Otsuka F, Gannon RL, Braumann RE, Dickinson MH, Gupta A, Jenkins AL, Lipinski MJ, Kim J, Chhour P, de Vries PS, Jinnouchi H, Kutys R, Mori H, Kutyna MD, Torii S, Sakamoto A, Choi CU, Cheng Q, Grove ML, Sawan MA, Zhang Y, Cao Y, Kolodgie FD, Cormode DP, Arking DE, Boerwinkle E, Morrison AC, Erdmann J, Sotoodehnia N, Virmani R, Finn AV.

J Clin Invest. 2018 Mar 1;128(3):1106-1124. doi: 10.1172/JCI93025. Epub 2018 Feb 19.

3.

CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury.

Akahori H, Karmali V, Polavarapu R, Lyle AN, Weiss D, Shin E, Husain A, Naqvi N, Van Dam R, Habib A, Choi CU, King AL, Pachura K, Taylor WR, Lefer DJ, Finn AV.

Nat Commun. 2015 Aug 5;6:7792. doi: 10.1038/ncomms8792.

4.

Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.

Habib A, Polavarapu R, Karmali V, Guo L, Van Dam R, Cheng Q, Akahori H, Saeed O, Nakano M, Pachura K, Hong CC, Shin E, Kolodgie F, Virmani R, Finn AV.

Atherosclerosis. 2015 Aug;241(2):692-700. doi: 10.1016/j.atherosclerosis.2015.06.025. Epub 2015 Jun 19.

5.

Everolimus-eluting stents improve vascular response in a diabetic animal model.

Habib A, Karmali V, John MC, Polavarapu R, Nakazawa G, Pachura K, Davis T, Kolodgie FD, Virmani R, Finn AV.

Circ Cardiovasc Interv. 2014 Aug;7(4):526-32. doi: 10.1161/CIRCINTERVENTIONS.113.001023. Epub 2014 Jun 10.

6.

Sirolimus-FKBP12.6 impairs endothelial barrier function through protein kinase C-α activation and disruption of the p120-vascular endothelial cadherin interaction.

Habib A, Karmali V, Polavarapu R, Akahori H, Cheng Q, Pachura K, Kolodgie FD, Finn AV.

Arterioscler Thromb Vasc Biol. 2013 Oct;33(10):2425-31. doi: 10.1161/ATVBAHA.113.301659. Epub 2013 Jul 25.

7.

Metformin impairs endothelialization after placement of newer generation drug eluting stents.

Habib A, Karmali V, Polavarapu R, Akahori H, Pachura K, Finn AV.

Atherosclerosis. 2013 Aug;229(2):385-7. doi: 10.1016/j.atherosclerosis.2013.06.001. Epub 2013 Jun 14.

8.

Metformin impairs vascular endothelial recovery after stent placement in the setting of locally eluted mammalian target of rapamycin inhibitors via S6 kinase-dependent inhibition of cell proliferation.

Habib A, Karmali V, Polavarapu R, Akahori H, Nakano M, Yazdani S, Otsuka F, Pachura K, Davis T, Narula J, Kolodgie FD, Virmani R, Finn AV.

J Am Coll Cardiol. 2013 Mar 5;61(9):971-80. doi: 10.1016/j.jacc.2012.12.018.

9.

Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques.

Finn AV, Nakano M, Polavarapu R, Karmali V, Saeed O, Zhao X, Yazdani S, Otsuka F, Davis T, Habib A, Narula J, Kolodgie FD, Virmani R.

J Am Coll Cardiol. 2012 Jan 10;59(2):166-77. doi: 10.1016/j.jacc.2011.10.852. Epub 2011 Dec 9.

10.

Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis.

Saeed O, Otsuka F, Polavarapu R, Karmali V, Weiss D, Davis T, Rostad B, Pachura K, Adams L, Elliott J, Taylor WR, Narula J, Kolodgie F, Virmani R, Hong CC, Finn AV.

Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):299-307. doi: 10.1161/ATVBAHA.111.240101. Epub 2011 Nov 17.

11.

Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.

Finn AV, John M, Nakazawa G, Polavarapu R, Karmali V, Xu X, Cheng Q, Davis T, Raghunathan C, Acampado E, Ezell T, Lajoie S, Eppihimer M, Kolodgie FD, Virmani R, Gold HK.

Circ Res. 2009 Nov 6;105(10):1003-12. doi: 10.1161/CIRCRESAHA.109.200519. Epub 2009 Sep 24.

12.

Loss of LR11/SORLA enhances early pathology in a mouse model of amyloidosis: evidence for a proximal role in Alzheimer's disease.

Dodson SE, Andersen OM, Karmali V, Fritz JJ, Cheng D, Peng J, Levey AI, Willnow TE, Lah JJ.

J Neurosci. 2008 Nov 26;28(48):12877-86. doi: 10.1523/JNEUROSCI.4582-08.2008.

13.

Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL.

Science. 2000 Sep 1;289(5484):1560-3.

Supplemental Content

Loading ...
Support Center